

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.88053379 |
| 2 | vocalization behavior (GO:0071625) | 5.61432662 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.43290359 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.33749882 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.28015306 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.11427094 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.09153373 |
| 8 | protein localization to synapse (GO:0035418) | 5.08652616 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.05941477 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.04420409 |
| 11 | locomotory exploration behavior (GO:0035641) | 5.01279576 |
| 12 | glutamate secretion (GO:0014047) | 4.94634970 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.79665807 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.62609224 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.56417097 |
| 16 | exploration behavior (GO:0035640) | 4.48347538 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.37248295 |
| 18 | sodium ion export (GO:0071436) | 4.35911265 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.25123868 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 4.24416571 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.23025725 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.17396968 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 4.09777426 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.08976916 |
| 25 | neuron recognition (GO:0008038) | 4.08883336 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.07918227 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 4.02038398 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.00247412 |
| 29 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.89622393 |
| 30 | proline transport (GO:0015824) | 3.89400303 |
| 31 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.80787074 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 3.79954657 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.79944495 |
| 34 | regulation of synapse structural plasticity (GO:0051823) | 3.74867776 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.72360943 |
| 36 | neurotransmitter transport (GO:0006836) | 3.64888430 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.63718158 |
| 38 | transmission of nerve impulse (GO:0019226) | 3.63068880 |
| 39 | axonal fasciculation (GO:0007413) | 3.60767723 |
| 40 | presynaptic membrane assembly (GO:0097105) | 3.60044345 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.58759804 |
| 42 | cerebellar granule cell differentiation (GO:0021707) | 3.58583251 |
| 43 | postsynaptic membrane organization (GO:0001941) | 3.56933038 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.56104904 |
| 45 | long-term memory (GO:0007616) | 3.55718273 |
| 46 | startle response (GO:0001964) | 3.55717508 |
| 47 | positive regulation of synapse maturation (GO:0090129) | 3.54684826 |
| 48 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.54507072 |
| 49 | gamma-aminobutyric acid transport (GO:0015812) | 3.53366422 |
| 50 | L-amino acid import (GO:0043092) | 3.52700744 |
| 51 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.52647833 |
| 52 | response to histamine (GO:0034776) | 3.52415663 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52259500 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.46953573 |
| 55 | positive regulation of membrane potential (GO:0045838) | 3.46727279 |
| 56 | nucleobase catabolic process (GO:0046113) | 3.45271215 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.43890132 |
| 58 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.43041751 |
| 59 | establishment of mitochondrion localization (GO:0051654) | 3.42764256 |
| 60 | neuronal ion channel clustering (GO:0045161) | 3.40415277 |
| 61 | regulation of neurotransmitter levels (GO:0001505) | 3.39810344 |
| 62 | cell migration in hindbrain (GO:0021535) | 3.39246596 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.38961082 |
| 64 | synaptic vesicle endocytosis (GO:0048488) | 3.38093961 |
| 65 | presynaptic membrane organization (GO:0097090) | 3.35376341 |
| 66 | regulation of synaptic plasticity (GO:0048167) | 3.34034317 |
| 67 | activation of protein kinase A activity (GO:0034199) | 3.33251102 |
| 68 | amino acid import (GO:0043090) | 3.33074135 |
| 69 | long-term synaptic potentiation (GO:0060291) | 3.29314247 |
| 70 | regulation of neurotransmitter secretion (GO:0046928) | 3.28980068 |
| 71 | potassium ion homeostasis (GO:0055075) | 3.28978804 |
| 72 | regulation of glutamate secretion (GO:0014048) | 3.28876614 |
| 73 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.28263453 |
| 74 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.25499409 |
| 75 | potassium ion import (GO:0010107) | 3.22865606 |
| 76 | behavioral fear response (GO:0001662) | 3.21672017 |
| 77 | behavioral defense response (GO:0002209) | 3.21672017 |
| 78 | central nervous system myelination (GO:0022010) | 3.21504545 |
| 79 | axon ensheathment in central nervous system (GO:0032291) | 3.21504545 |
| 80 | synapse assembly (GO:0007416) | 3.21395482 |
| 81 | innervation (GO:0060384) | 3.21258640 |
| 82 | detection of calcium ion (GO:0005513) | 3.20397930 |
| 83 | mechanosensory behavior (GO:0007638) | 3.19100869 |
| 84 | positive regulation of synapse assembly (GO:0051965) | 3.18071423 |
| 85 | cell communication by electrical coupling (GO:0010644) | 3.18028135 |
| 86 | neuromuscular synaptic transmission (GO:0007274) | 3.17952423 |
| 87 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17398361 |
| 88 | cellular sodium ion homeostasis (GO:0006883) | 3.16291017 |
| 89 | membrane depolarization (GO:0051899) | 3.14375763 |
| 90 | positive regulation of neurotransmitter transport (GO:0051590) | 3.13669102 |
| 91 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.11676843 |
| 92 | fear response (GO:0042596) | 3.11496620 |
| 93 | negative regulation of microtubule polymerization (GO:0031115) | 3.11362750 |
| 94 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.10825612 |
| 95 | intraspecies interaction between organisms (GO:0051703) | 3.10781263 |
| 96 | social behavior (GO:0035176) | 3.10781263 |
| 97 | learning (GO:0007612) | 3.10710077 |
| 98 | membrane depolarization during action potential (GO:0086010) | 3.10456133 |
| 99 | auditory behavior (GO:0031223) | 3.09498953 |
| 100 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.07871917 |
| 101 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.07710670 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 3.07293648 |
| 103 | mating behavior (GO:0007617) | 3.06811425 |
| 104 | synaptic transmission (GO:0007268) | 3.05411575 |
| 105 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04419035 |
| 106 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.03637224 |
| 107 | neurotransmitter uptake (GO:0001504) | 3.03498691 |
| 108 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.02369096 |
| 109 | behavioral response to cocaine (GO:0048148) | 3.02252102 |
| 110 | response to auditory stimulus (GO:0010996) | 3.01944254 |
| 111 | vesicle transport along microtubule (GO:0047496) | 3.01924114 |
| 112 | cellular potassium ion homeostasis (GO:0030007) | 3.00284342 |
| 113 | negative regulation of dendrite development (GO:2000171) | 2.99875834 |
| 114 | membrane hyperpolarization (GO:0060081) | 2.99126915 |
| 115 | regulation of dendritic spine development (GO:0060998) | 2.98245564 |
| 116 | serotonin metabolic process (GO:0042428) | 2.97308681 |
| 117 | neuromuscular process controlling balance (GO:0050885) | 2.97059072 |
| 118 | synaptic vesicle transport (GO:0048489) | 2.96973435 |
| 119 | establishment of synaptic vesicle localization (GO:0097480) | 2.96973435 |
| 120 | neuromuscular process controlling posture (GO:0050884) | 2.96855557 |
| 121 | positive regulation of dendritic spine development (GO:0060999) | 2.96617410 |
| 122 | dendrite morphogenesis (GO:0048813) | 2.95506788 |
| 123 | regulation of synapse maturation (GO:0090128) | 2.94277497 |
| 124 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94273075 |
| 125 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.94010484 |
| 126 | dendritic spine organization (GO:0097061) | 2.91955204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.33421697 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.02692971 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19651798 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.12488774 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01911061 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84222354 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62296372 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61906803 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61906803 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61426012 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56397571 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50887503 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.49470064 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45604068 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.43466053 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39121514 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38535833 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.38425629 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29876298 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.28550790 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.27254889 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.20489534 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12479016 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12341794 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08981175 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.08720582 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.08034714 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06197615 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05134340 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94875632 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86207901 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84297733 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79222272 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.71556747 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70527842 |
| 36 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.68937611 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.68724352 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67756633 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55818586 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53123311 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50141983 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46708437 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46488488 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45099430 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44761383 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44717401 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44576356 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44293869 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.43678727 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.40809879 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39755471 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37341000 |
| 53 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36408659 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36365652 |
| 55 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35676504 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34924647 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34719747 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31525092 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30960630 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30885484 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30328052 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25199095 |
| 63 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23974982 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23774381 |
| 65 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23192850 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18584365 |
| 67 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17150818 |
| 68 | JUN_21703547_ChIP-Seq_K562_Human | 1.15880506 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.14264539 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12442863 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10272011 |
| 72 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08915070 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07965301 |
| 74 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07444860 |
| 75 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06361747 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06332644 |
| 77 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06268374 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04824576 |
| 79 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03934921 |
| 80 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03755929 |
| 81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.02256051 |
| 82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02151724 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01982468 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01710259 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99558582 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96533351 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96533351 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96119369 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96045065 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95824997 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95569077 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93542765 |
| 93 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93541384 |
| 94 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93076187 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92937577 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92421547 |
| 97 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.92224063 |
| 98 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91852136 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91823733 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91606697 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91018873 |
| 102 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.90913462 |
| 103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90898342 |
| 104 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89990262 |
| 105 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89900941 |
| 106 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.89900941 |
| 107 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.89018172 |
| 108 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87768129 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86848585 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86798523 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85561856 |
| 112 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.85421030 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84595066 |
| 114 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.83672272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.81018897 |
| 2 | MP0003880_abnormal_central_pattern | 5.01347295 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.97517686 |
| 4 | MP0004270_analgesia | 3.78150572 |
| 5 | MP0009745_abnormal_behavioral_response | 3.41471504 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.40923892 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.26849148 |
| 8 | MP0002064_seizures | 3.06526263 |
| 9 | MP0009046_muscle_twitch | 2.98911026 |
| 10 | MP0002735_abnormal_chemical_nociception | 2.92371303 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.85216616 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.78608931 |
| 13 | MP0002736_abnormal_nociception_after | 2.72992759 |
| 14 | MP0002822_catalepsy | 2.69405958 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.63788175 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.55600441 |
| 17 | MP0002272_abnormal_nervous_system | 2.52564820 |
| 18 | MP0001486_abnormal_startle_reflex | 2.43514688 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.35404398 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.34871837 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.29677219 |
| 22 | MP0001529_abnormal_vocalization | 2.18372236 |
| 23 | MP0001970_abnormal_pain_threshold | 2.13932300 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.01472853 |
| 25 | MP0002184_abnormal_innervation | 2.00162956 |
| 26 | MP0000778_abnormal_nervous_system | 1.94144714 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.86816592 |
| 28 | MP0004924_abnormal_behavior | 1.86816592 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.81611355 |
| 30 | MP0003122_maternal_imprinting | 1.73683253 |
| 31 | MP0004858_abnormal_nervous_system | 1.71042646 |
| 32 | MP0001905_abnormal_dopamine_level | 1.68722856 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.68620352 |
| 34 | MP0001984_abnormal_olfaction | 1.62646240 |
| 35 | MP0003329_amyloid_beta_deposits | 1.61133921 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.60264564 |
| 37 | MP0003787_abnormal_imprinting | 1.54781602 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.53042592 |
| 39 | MP0000955_abnormal_spinal_cord | 1.52992141 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.50049745 |
| 41 | MP0008569_lethality_at_weaning | 1.48793396 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.45980061 |
| 43 | MP0001188_hyperpigmentation | 1.44783492 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.41135282 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.40536499 |
| 46 | MP0003879_abnormal_hair_cell | 1.38460656 |
| 47 | MP0004142_abnormal_muscle_tone | 1.33915765 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.19801846 |
| 49 | MP0003690_abnormal_glial_cell | 1.12835196 |
| 50 | MP0002152_abnormal_brain_morphology | 1.12624495 |
| 51 | MP0000751_myopathy | 1.12302681 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.09547258 |
| 53 | MP0008872_abnormal_physiological_respon | 1.07623475 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.07258228 |
| 55 | MP0003633_abnormal_nervous_system | 1.04061118 |
| 56 | MP0004885_abnormal_endolymph | 1.02178882 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.01388029 |
| 58 | MP0000920_abnormal_myelination | 1.00949225 |
| 59 | MP0002876_abnormal_thyroid_physiology | 0.99737051 |
| 60 | MP0002102_abnormal_ear_morphology | 0.97466791 |
| 61 | MP0001986_abnormal_taste_sensitivity | 0.96819928 |
| 62 | MP0003631_nervous_system_phenotype | 0.95508244 |
| 63 | MP0002229_neurodegeneration | 0.92843797 |
| 64 | MP0002069_abnormal_eating/drinking_beha | 0.92434617 |
| 65 | MP0005499_abnormal_olfactory_system | 0.92347854 |
| 66 | MP0005394_taste/olfaction_phenotype | 0.92347854 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 0.91272183 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 0.88843928 |
| 69 | MP0004147_increased_porphyrin_level | 0.88056132 |
| 70 | MP0001963_abnormal_hearing_physiology | 0.87494578 |
| 71 | MP0002752_abnormal_somatic_nervous | 0.85984001 |
| 72 | MP0004742_abnormal_vestibular_system | 0.85813179 |
| 73 | MP0004085_abnormal_heartbeat | 0.85558883 |
| 74 | MP0005623_abnormal_meninges_morphology | 0.85024779 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.82442636 |
| 76 | MP0003123_paternal_imprinting | 0.82281098 |
| 77 | MP0008874_decreased_physiological_sensi | 0.82159459 |
| 78 | MP0005535_abnormal_body_temperature | 0.81666902 |
| 79 | MP0003121_genomic_imprinting | 0.81630182 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 0.80123994 |
| 81 | MP0005253_abnormal_eye_physiology | 0.77575691 |
| 82 | MP0005409_darkened_coat_color | 0.75382057 |
| 83 | MP0003634_abnormal_glial_cell | 0.72008560 |
| 84 | MP0005187_abnormal_penis_morphology | 0.71924814 |
| 85 | MP0002751_abnormal_autonomic_nervous | 0.71105751 |
| 86 | MP0003632_abnormal_nervous_system | 0.69888431 |
| 87 | MP0001664_abnormal_digestion | 0.69262563 |
| 88 | MP0006072_abnormal_retinal_apoptosis | 0.67594795 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.67445354 |
| 90 | MP0004215_abnormal_myocardial_fiber | 0.65699358 |
| 91 | MP0003938_abnormal_ear_development | 0.65667442 |
| 92 | MP0001177_atelectasis | 0.64897102 |
| 93 | MP0003861_abnormal_nervous_system | 0.64860884 |
| 94 | MP0004133_heterotaxia | 0.64410928 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.63142907 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.62794112 |
| 97 | MP0000604_amyloidosis | 0.62766287 |
| 98 | MP0004484_altered_response_of | 0.61460982 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.60743318 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.59784129 |
| 101 | MP0003283_abnormal_digestive_organ | 0.59774111 |
| 102 | MP0001943_abnormal_respiration | 0.59378138 |
| 103 | MP0000026_abnormal_inner_ear | 0.59304585 |
| 104 | MP0005171_absent_coat_pigmentation | 0.59180586 |
| 105 | MP0010768_mortality/aging | 0.59139844 |
| 106 | MP0000569_abnormal_digit_pigmentation | 0.56657136 |
| 107 | MP0004233_abnormal_muscle_weight | 0.56132936 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.54707451 |
| 109 | MP0004043_abnormal_pH_regulation | 0.54418461 |
| 110 | MP0010770_preweaning_lethality | 0.53411312 |
| 111 | MP0002082_postnatal_lethality | 0.53411312 |
| 112 | MP0010769_abnormal_survival | 0.52551449 |
| 113 | MP0002090_abnormal_vision | 0.51896433 |
| 114 | MP0001348_abnormal_lacrimal_gland | 0.50696542 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.50655523 |
| 116 | MP0003956_abnormal_body_size | 0.50623480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.80549479 |
| 2 | Myokymia (HP:0002411) | 6.53333904 |
| 3 | Focal seizures (HP:0007359) | 5.68536833 |
| 4 | Atonic seizures (HP:0010819) | 5.02037346 |
| 5 | Visual hallucinations (HP:0002367) | 4.97711423 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.77346383 |
| 7 | Febrile seizures (HP:0002373) | 4.52713885 |
| 8 | Absence seizures (HP:0002121) | 4.39204435 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.01583031 |
| 10 | Dialeptic seizures (HP:0011146) | 4.00744452 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.83915062 |
| 12 | Hyperventilation (HP:0002883) | 3.58847827 |
| 13 | Limb dystonia (HP:0002451) | 3.48192555 |
| 14 | Broad-based gait (HP:0002136) | 3.47609894 |
| 15 | Amblyopia (HP:0000646) | 3.20303562 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.18150216 |
| 17 | Action tremor (HP:0002345) | 3.14281608 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.09312272 |
| 19 | Progressive inability to walk (HP:0002505) | 3.04896895 |
| 20 | Poor eye contact (HP:0000817) | 2.99467664 |
| 21 | Ankle clonus (HP:0011448) | 2.95065611 |
| 22 | Pheochromocytoma (HP:0002666) | 2.92506733 |
| 23 | Abnormal eating behavior (HP:0100738) | 2.91706841 |
| 24 | Anxiety (HP:0000739) | 2.86307090 |
| 25 | Truncal ataxia (HP:0002078) | 2.85777664 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 2.81800328 |
| 27 | Termporal pattern (HP:0011008) | 2.81013332 |
| 28 | Insidious onset (HP:0003587) | 2.81013332 |
| 29 | Drooling (HP:0002307) | 2.80102127 |
| 30 | Excessive salivation (HP:0003781) | 2.80102127 |
| 31 | Mutism (HP:0002300) | 2.80032509 |
| 32 | Polyphagia (HP:0002591) | 2.79637160 |
| 33 | Dysdiadochokinesis (HP:0002075) | 2.79173619 |
| 34 | Depression (HP:0000716) | 2.77493245 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.75848920 |
| 36 | Hemiplegia (HP:0002301) | 2.70620376 |
| 37 | Impaired social interactions (HP:0000735) | 2.64560424 |
| 38 | Abnormal social behavior (HP:0012433) | 2.64560424 |
| 39 | Neuroendocrine neoplasm (HP:0100634) | 2.64017929 |
| 40 | Urinary urgency (HP:0000012) | 2.62332358 |
| 41 | Abnormality of the corticospinal tract (HP:0002492) | 2.61647867 |
| 42 | Dysmetria (HP:0001310) | 2.60156009 |
| 43 | Inability to walk (HP:0002540) | 2.58394837 |
| 44 | Epileptiform EEG discharges (HP:0011182) | 2.55062786 |
| 45 | Gait imbalance (HP:0002141) | 2.53202991 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.50400167 |
| 47 | Intention tremor (HP:0002080) | 2.47658580 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.43417154 |
| 49 | Papilledema (HP:0001085) | 2.42827913 |
| 50 | Abnormality of binocular vision (HP:0011514) | 2.41125748 |
| 51 | Diplopia (HP:0000651) | 2.41125748 |
| 52 | Absent speech (HP:0001344) | 2.41057207 |
| 53 | Sleep apnea (HP:0010535) | 2.40684033 |
| 54 | Spastic gait (HP:0002064) | 2.37581892 |
| 55 | Postural instability (HP:0002172) | 2.34309261 |
| 56 | Fetal akinesia sequence (HP:0001989) | 2.33833361 |
| 57 | Bradykinesia (HP:0002067) | 2.29666908 |
| 58 | Hypsarrhythmia (HP:0002521) | 2.28064501 |
| 59 | Hemiparesis (HP:0001269) | 2.27638651 |
| 60 | Amyotrophic lateral sclerosis (HP:0007354) | 2.27485409 |
| 61 | Torticollis (HP:0000473) | 2.24707163 |
| 62 | Neurofibrillary tangles (HP:0002185) | 2.24358777 |
| 63 | Abnormality of the lower motor neuron (HP:0002366) | 2.23901237 |
| 64 | Failure to thrive in infancy (HP:0001531) | 2.22156016 |
| 65 | Cerebral hypomyelination (HP:0006808) | 2.18282921 |
| 66 | Delusions (HP:0000746) | 2.17670278 |
| 67 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.17302192 |
| 68 | Focal dystonia (HP:0004373) | 2.16927399 |
| 69 | Scanning speech (HP:0002168) | 2.16421143 |
| 70 | Spastic tetraplegia (HP:0002510) | 2.15800630 |
| 71 | Split foot (HP:0001839) | 2.14595487 |
| 72 | Genetic anticipation (HP:0003743) | 2.13324914 |
| 73 | Hypoventilation (HP:0002791) | 2.11955369 |
| 74 | Impaired smooth pursuit (HP:0007772) | 2.10638103 |
| 75 | Protruding tongue (HP:0010808) | 2.10242675 |
| 76 | Spastic tetraparesis (HP:0001285) | 2.10228955 |
| 77 | Specific learning disability (HP:0001328) | 2.09115358 |
| 78 | Lower limb muscle weakness (HP:0007340) | 2.08022490 |
| 79 | Megalencephaly (HP:0001355) | 2.07526364 |
| 80 | Stereotypic behavior (HP:0000733) | 2.07068832 |
| 81 | Retinal dysplasia (HP:0007973) | 2.03278115 |
| 82 | Generalized myoclonic seizures (HP:0002123) | 2.01971598 |
| 83 | Impaired vibratory sensation (HP:0002495) | 2.01420579 |
| 84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.01107756 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.01107756 |
| 86 | Congenital primary aphakia (HP:0007707) | 2.00795770 |
| 87 | Agitation (HP:0000713) | 2.00440096 |
| 88 | Akinesia (HP:0002304) | 2.00378231 |
| 89 | Status epilepticus (HP:0002133) | 1.97806445 |
| 90 | Blue irides (HP:0000635) | 1.96922639 |
| 91 | Craniofacial dystonia (HP:0012179) | 1.96793799 |
| 92 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.94466734 |
| 93 | Hypoplasia of the brainstem (HP:0002365) | 1.94466734 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 1.94242581 |
| 95 | Abnormal hair whorl (HP:0010721) | 1.92603380 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 1.92598160 |
| 97 | Abnormality of salivation (HP:0100755) | 1.92460684 |
| 98 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.92098248 |
| 99 | Poor suck (HP:0002033) | 1.91402201 |
| 100 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.91227703 |
| 101 | Exotropia (HP:0000577) | 1.90349745 |
| 102 | Incomplete penetrance (HP:0003829) | 1.89120466 |
| 103 | Lissencephaly (HP:0001339) | 1.88670783 |
| 104 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86686278 |
| 105 | Clonus (HP:0002169) | 1.86392612 |
| 106 | Psychosis (HP:0000709) | 1.85821406 |
| 107 | Abnormality of the labia minora (HP:0012880) | 1.85387683 |
| 108 | Progressive macrocephaly (HP:0004481) | 1.84885414 |
| 109 | Abnormality of pain sensation (HP:0010832) | 1.84066536 |
| 110 | Impaired pain sensation (HP:0007328) | 1.84066536 |
| 111 | Tetraplegia (HP:0002445) | 1.83581439 |
| 112 | Hypoplasia of the corpus callosum (HP:0002079) | 1.83482108 |
| 113 | Genital tract atresia (HP:0001827) | 1.81967543 |
| 114 | Type II lissencephaly (HP:0007260) | 1.81216257 |
| 115 | Hyperthyroidism (HP:0000836) | 1.80395617 |
| 116 | Gait ataxia (HP:0002066) | 1.80349356 |
| 117 | Muscular hypotonia of the trunk (HP:0008936) | 1.79398671 |
| 118 | Peripheral hypomyelination (HP:0007182) | 1.77312897 |
| 119 | Annular pancreas (HP:0001734) | 1.74474892 |
| 120 | Neuronal loss in central nervous system (HP:0002529) | 1.73357233 |
| 121 | Vaginal atresia (HP:0000148) | 1.72922605 |
| 122 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.72249113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.37246821 |
| 2 | EPHA4 | 3.67436409 |
| 3 | MARK1 | 3.64196074 |
| 4 | MAP3K9 | 3.62127436 |
| 5 | MAP3K4 | 3.46933938 |
| 6 | MAP2K7 | 2.95908725 |
| 7 | MINK1 | 2.86716727 |
| 8 | CASK | 2.76340846 |
| 9 | MAP3K12 | 2.74139369 |
| 10 | PNCK | 2.23710615 |
| 11 | MAP2K4 | 2.20008572 |
| 12 | NTRK2 | 2.12358123 |
| 13 | DAPK2 | 1.99626783 |
| 14 | KSR2 | 1.90601510 |
| 15 | PLK2 | 1.90385120 |
| 16 | NTRK1 | 1.90061852 |
| 17 | PINK1 | 1.85065775 |
| 18 | RIPK4 | 1.82646411 |
| 19 | PAK6 | 1.81051639 |
| 20 | KSR1 | 1.65828470 |
| 21 | MAPK13 | 1.65801761 |
| 22 | GRK5 | 1.63513869 |
| 23 | TNIK | 1.61794200 |
| 24 | MAP4K2 | 1.56515946 |
| 25 | DAPK1 | 1.54844247 |
| 26 | ARAF | 1.52455214 |
| 27 | CDK5 | 1.45258640 |
| 28 | CDK19 | 1.37375439 |
| 29 | LATS2 | 1.34614187 |
| 30 | FRK | 1.33484288 |
| 31 | PRKCG | 1.28854739 |
| 32 | PRPF4B | 1.22982567 |
| 33 | CAMKK1 | 1.21886471 |
| 34 | SIK2 | 1.17900258 |
| 35 | UHMK1 | 1.13149663 |
| 36 | PRKD3 | 1.10506076 |
| 37 | CAMK2A | 1.10035271 |
| 38 | PHKG2 | 1.09997484 |
| 39 | PHKG1 | 1.09997484 |
| 40 | FES | 1.00286054 |
| 41 | NME1 | 0.98039332 |
| 42 | CDK14 | 0.95708374 |
| 43 | CDK18 | 0.95559425 |
| 44 | MAP3K2 | 0.94825097 |
| 45 | CAMKK2 | 0.93976019 |
| 46 | FGFR2 | 0.93629926 |
| 47 | CAMK2B | 0.92189783 |
| 48 | CDK15 | 0.90880307 |
| 49 | PKN1 | 0.89553055 |
| 50 | TRIM28 | 0.85922902 |
| 51 | CSNK1G2 | 0.84083452 |
| 52 | PAK3 | 0.82077043 |
| 53 | STK38 | 0.81491192 |
| 54 | CDK11A | 0.79503585 |
| 55 | CSNK1A1L | 0.79096248 |
| 56 | PTK2B | 0.78141446 |
| 57 | OXSR1 | 0.77267924 |
| 58 | EPHA3 | 0.76891042 |
| 59 | MAP3K13 | 0.76866887 |
| 60 | BMPR2 | 0.76307987 |
| 61 | SGK223 | 0.75412619 |
| 62 | SGK494 | 0.75412619 |
| 63 | RAF1 | 0.75272161 |
| 64 | AKT3 | 0.75179372 |
| 65 | GRK7 | 0.73921059 |
| 66 | CCNB1 | 0.72471626 |
| 67 | RET | 0.69490604 |
| 68 | DYRK1A | 0.69086355 |
| 69 | CSNK1G1 | 0.67967494 |
| 70 | STK11 | 0.67474248 |
| 71 | TYRO3 | 0.67109215 |
| 72 | CAMK4 | 0.66549221 |
| 73 | BCR | 0.65894288 |
| 74 | WNK3 | 0.65562067 |
| 75 | SGK2 | 0.64407628 |
| 76 | SIK3 | 0.61621492 |
| 77 | TNK2 | 0.60662761 |
| 78 | PRKCE | 0.60441305 |
| 79 | CAMK1 | 0.60376365 |
| 80 | FGR | 0.58606124 |
| 81 | SGK1 | 0.57846427 |
| 82 | FER | 0.57122435 |
| 83 | DYRK2 | 0.55357773 |
| 84 | CAMK2D | 0.52807649 |
| 85 | LIMK1 | 0.51018790 |
| 86 | PRKCZ | 0.50675311 |
| 87 | LMTK2 | 0.49255080 |
| 88 | BRAF | 0.48867284 |
| 89 | MARK2 | 0.47548640 |
| 90 | CAMK2G | 0.47365414 |
| 91 | TSSK6 | 0.47216753 |
| 92 | MAP2K1 | 0.46827168 |
| 93 | BMPR1B | 0.46586885 |
| 94 | ADRBK1 | 0.46080062 |
| 95 | CAMK1G | 0.45889805 |
| 96 | ADRBK2 | 0.45811097 |
| 97 | CSNK1D | 0.44034589 |
| 98 | SCYL2 | 0.43994340 |
| 99 | INSRR | 0.43543569 |
| 100 | ALK | 0.43397929 |
| 101 | WNK4 | 0.42653717 |
| 102 | CSNK1G3 | 0.42642205 |
| 103 | NEK6 | 0.40792182 |
| 104 | RPS6KA3 | 0.39114710 |
| 105 | STK39 | 0.38856541 |
| 106 | MAPK10 | 0.38783455 |
| 107 | ERBB3 | 0.38775110 |
| 108 | PRKACA | 0.36522044 |
| 109 | PRKCH | 0.36130682 |
| 110 | CSNK1A1 | 0.35083883 |
| 111 | CSNK1E | 0.34843455 |
| 112 | SGK3 | 0.34806250 |
| 113 | TAOK1 | 0.34792343 |
| 114 | PRKG1 | 0.34503152 |
| 115 | MAP3K6 | 0.34467595 |
| 116 | DAPK3 | 0.34120406 |
| 117 | RPS6KA2 | 0.34069533 |
| 118 | PRKCB | 0.33137929 |
| 119 | MAP3K1 | 0.32663231 |
| 120 | ROCK2 | 0.32008274 |
| 121 | PRKCA | 0.31941692 |
| 122 | FYN | 0.31468328 |
| 123 | ERBB2 | 0.31362068 |
| 124 | PRKAA1 | 0.30632231 |
| 125 | CDK3 | 0.30495844 |
| 126 | BRSK1 | 0.28940242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.17172378 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.55785415 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.84900063 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.77315940 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.73546713 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.67921812 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.59490464 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57600338 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.52380539 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.49246684 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.34765907 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.17352301 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14363924 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.05419573 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.01570655 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.93556257 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.86218415 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85912815 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.80942655 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.80308679 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74340034 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71143017 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60446954 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60001555 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59218340 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58277897 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58265802 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.55577464 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44116996 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42807999 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.41604511 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35341110 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31881704 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31381139 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30171709 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.28351509 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.24832362 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11997491 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09059172 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06762797 |
| 41 | Melanogenesis_Homo sapiens_hsa04916 | 1.06580003 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05934524 |
| 43 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.04263465 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02167550 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99129876 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96899092 |
| 47 | Glioma_Homo sapiens_hsa05214 | 0.95602438 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.93345845 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92771761 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92663944 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91989397 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91422259 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91186546 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86421581 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85134866 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80252541 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76714377 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73944323 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70514911 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.68538866 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67879158 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.65810052 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65611752 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64236550 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62538517 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60714235 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59658614 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57157440 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53950918 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53885115 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53195886 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53161491 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52588379 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52202140 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51615520 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50449231 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.46978814 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46287584 |
| 79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46160555 |
| 80 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45952452 |
| 81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45558449 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44798842 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43967534 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43416182 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42614402 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42552145 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42320589 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41905033 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40922738 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39641504 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38678478 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37130053 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36512775 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36213030 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36106070 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34966158 |
| 97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34870711 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34485082 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34333988 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33780578 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33595346 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32460866 |
| 103 | Protein export_Homo sapiens_hsa03060 | 0.32453735 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31691783 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31184874 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30870339 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29074726 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.28856580 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28694346 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28293848 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26764507 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26362485 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26354282 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26210143 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.26079420 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25751958 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25266111 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.24863948 |
| 119 | Tight junction_Homo sapiens_hsa04530 | 0.24384583 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23487212 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.22625277 |

